Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-01-30

AUTHORS

Yoshimitsu Soga, Yusuke Tomoi, Kei Sato, Osamu Iida, Hiroyoshi Yokoi

ABSTRACT

The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8 %. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5 % (75.5 %) and 46.9 % (56.2 %), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2 % at 5-year, p = 0.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2 % at 5-year, p = 0.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency. More... »

PAGES

250-257

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1

DOI

http://dx.doi.org/10.1007/s12928-013-0164-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035385457

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23361951


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arterial Occlusive Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aspirin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Endovascular Procedures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femoral Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Platelet Aggregation Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Popliteal Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vascular Patency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soga", 
        "givenName": "Yoshimitsu", 
        "id": "sg:person.01276714415.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276714415.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomoi", 
        "givenName": "Yusuke", 
        "id": "sg:person.01104331243.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104331243.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.414976.9", 
          "name": [
            "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato", 
        "givenName": "Kei", 
        "id": "sg:person.01222237135.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222237135.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan", 
          "id": "http://www.grid.ac/institutes/grid.414976.9", 
          "name": [
            "Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iida", 
        "givenName": "Osamu", 
        "id": "sg:person.01016335235.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016335235.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan", 
          "id": "http://www.grid.ac/institutes/grid.415432.5", 
          "name": [
            "Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yokoi", 
        "givenName": "Hiroyoshi", 
        "id": "sg:person.01052603744.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052603744.16"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2013-01-30", 
    "datePublishedReg": "2013-01-30", 
    "description": "The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8\u00a0%. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5\u00a0% (75.5\u00a0%) and 46.9\u00a0% (56.2\u00a0%), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2\u00a0% at 5-year, p\u00a0=\u00a00.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2\u00a0% at 5-year, p\u00a0=\u00a00.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12928-013-0164-1", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1042779", 
        "issn": [
          "1868-4300", 
          "1868-4297"
        ], 
        "name": "Cardiovascular Intervention and Therapeutics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "28"
      }
    ], 
    "keywords": [
      "common femoral artery", 
      "endovascular treatment", 
      "popliteal artery", 
      "primary patency", 
      "secondary patency", 
      "residual stenosis", 
      "artery disease", 
      "stent placement", 
      "PA lesions", 
      "multicenter retrospective registry", 
      "popliteal artery disease", 
      "primary patency rate", 
      "reference vessel diameter", 
      "coronary artery disease", 
      "short-term patency", 
      "long-term patency", 
      "reduction of restenosis", 
      "retrospective registry", 
      "CFA lesions", 
      "renal failure", 
      "independent predictors", 
      "clinical outcomes", 
      "main endpoint", 
      "patency rates", 
      "femoral artery", 
      "procedure success", 
      "endovascular procedures", 
      "patency", 
      "multivariate analysis", 
      "lesions", 
      "disease", 
      "vessel diameter", 
      "stenosis", 
      "significant differences", 
      "artery", 
      "predictors", 
      "treatment", 
      "de novo", 
      "BMI", 
      "patients", 
      "anemia", 
      "registry", 
      "restenosis", 
      "placement", 
      "endpoint", 
      "efficacy", 
      "outcomes", 
      "study", 
      "safety", 
      "failure", 
      "novo", 
      "differences", 
      "database", 
      "rate", 
      "procedure", 
      "reduction", 
      "success", 
      "analysis", 
      "diameter"
    ], 
    "name": "Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease", 
    "pagination": "250-257", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035385457"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12928-013-0164-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23361951"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12928-013-0164-1", 
      "https://app.dimensions.ai/details/publication/pub.1035385457"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_594.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12928-013-0164-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12928-013-0164-1'


 

This table displays all metadata directly associated to this object as RDF triples.

227 TRIPLES      20 PREDICATES      103 URIs      95 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12928-013-0164-1 schema:about N07e3edad257e41ccbdc21bbafe5c0097
2 N0bbae4578d57454689180f446495ee20
3 N10208bd26c984f6196e48f09479edc8a
4 N2773dd816ca044e1b764d4f21f49f189
5 N2b37c688655e4320a0ccf60940787537
6 N38539921d8864f8bac2ae32a04bbef28
7 N55cc628892444fe49a92bb68c3695b82
8 N708b7f0ca8af4f1fb0d28e5bbae55ab5
9 N7133869320b84bc8a52e09429f756f75
10 N7e59b7e6b05c4fa4b77c1334e201e387
11 N8e3dd837c09a4408bfbb3c6773bedd55
12 N9eff0ff8350b4081b7e32fced162f5df
13 Nd2e6a089f69c4a11bea25a02ac99b316
14 Ne9e1cc8ef3694449a3a1014c116e12c4
15 Necbcbf21ace044aea72ded0a906f9224
16 Nf53b59bcc5d74eb3b29c41e25abc2d75
17 Nf6ec99423c854f71b7d7883e6d2ad7e5
18 Nf9a028d4b90641ef8de334e2ab07d795
19 Nfc9a7c84cb0f4f51ba5ef349bf1300e7
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author Nc8c88db3bd4a46539246e9d9bfbecd86
23 schema:datePublished 2013-01-30
24 schema:datePublishedReg 2013-01-30
25 schema:description The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8 %. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5 % (75.5 %) and 46.9 % (56.2 %), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2 % at 5-year, p = 0.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2 % at 5-year, p = 0.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N0b26ad80d2ed42e38e18ceddf310f9a7
29 N8b16c93469c64753a8dd37ac75524608
30 sg:journal.1042779
31 schema:keywords BMI
32 CFA lesions
33 PA lesions
34 analysis
35 anemia
36 artery
37 artery disease
38 clinical outcomes
39 common femoral artery
40 coronary artery disease
41 database
42 de novo
43 diameter
44 differences
45 disease
46 efficacy
47 endovascular procedures
48 endovascular treatment
49 endpoint
50 failure
51 femoral artery
52 independent predictors
53 lesions
54 long-term patency
55 main endpoint
56 multicenter retrospective registry
57 multivariate analysis
58 novo
59 outcomes
60 patency
61 patency rates
62 patients
63 placement
64 popliteal artery
65 popliteal artery disease
66 predictors
67 primary patency
68 primary patency rate
69 procedure
70 procedure success
71 rate
72 reduction
73 reduction of restenosis
74 reference vessel diameter
75 registry
76 renal failure
77 residual stenosis
78 restenosis
79 retrospective registry
80 safety
81 secondary patency
82 short-term patency
83 significant differences
84 stenosis
85 stent placement
86 study
87 success
88 treatment
89 vessel diameter
90 schema:name Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease
91 schema:pagination 250-257
92 schema:productId N33fb166780734a0a8ad29d828b45b622
93 N8900f04c98d74bbe9eda36ab0e01e58c
94 Nbf35d572220d4fd9ab65bb41b75afcd9
95 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035385457
96 https://doi.org/10.1007/s12928-013-0164-1
97 schema:sdDatePublished 2022-10-01T06:38
98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
99 schema:sdPublisher N530e9fca979a43049d2baa82b65c2f2c
100 schema:url https://doi.org/10.1007/s12928-013-0164-1
101 sgo:license sg:explorer/license/
102 sgo:sdDataset articles
103 rdf:type schema:ScholarlyArticle
104 N07e3edad257e41ccbdc21bbafe5c0097 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Platelet Aggregation Inhibitors
106 rdf:type schema:DefinedTerm
107 N0b26ad80d2ed42e38e18ceddf310f9a7 schema:issueNumber 3
108 rdf:type schema:PublicationIssue
109 N0bbae4578d57454689180f446495ee20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Aged, 80 and over
111 rdf:type schema:DefinedTerm
112 N10208bd26c984f6196e48f09479edc8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Prospective Studies
114 rdf:type schema:DefinedTerm
115 N2773dd816ca044e1b764d4f21f49f189 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Aged
117 rdf:type schema:DefinedTerm
118 N2b37c688655e4320a0ccf60940787537 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 N30e82e59b38a4cffa269d7ad96025182 rdf:first sg:person.01222237135.86
122 rdf:rest Na9b9b864e41a4774952b8c527644302f
123 N33fb166780734a0a8ad29d828b45b622 schema:name dimensions_id
124 schema:value pub.1035385457
125 rdf:type schema:PropertyValue
126 N38539921d8864f8bac2ae32a04bbef28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Male
128 rdf:type schema:DefinedTerm
129 N530e9fca979a43049d2baa82b65c2f2c schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 N55cc628892444fe49a92bb68c3695b82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Dose-Response Relationship, Drug
133 rdf:type schema:DefinedTerm
134 N708b7f0ca8af4f1fb0d28e5bbae55ab5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Follow-Up Studies
136 rdf:type schema:DefinedTerm
137 N7133869320b84bc8a52e09429f756f75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Arterial Occlusive Diseases
139 rdf:type schema:DefinedTerm
140 N7e59b7e6b05c4fa4b77c1334e201e387 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Female
142 rdf:type schema:DefinedTerm
143 N8900f04c98d74bbe9eda36ab0e01e58c schema:name pubmed_id
144 schema:value 23361951
145 rdf:type schema:PropertyValue
146 N8b16c93469c64753a8dd37ac75524608 schema:volumeNumber 28
147 rdf:type schema:PublicationVolume
148 N8e3dd837c09a4408bfbb3c6773bedd55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Femoral Artery
150 rdf:type schema:DefinedTerm
151 N9eff0ff8350b4081b7e32fced162f5df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Stents
153 rdf:type schema:DefinedTerm
154 Na9b9b864e41a4774952b8c527644302f rdf:first sg:person.01016335235.39
155 rdf:rest Naccb74097bd142b7ab93b198387bb61e
156 Naccb74097bd142b7ab93b198387bb61e rdf:first sg:person.01052603744.16
157 rdf:rest rdf:nil
158 Nbf35d572220d4fd9ab65bb41b75afcd9 schema:name doi
159 schema:value 10.1007/s12928-013-0164-1
160 rdf:type schema:PropertyValue
161 Nc8c88db3bd4a46539246e9d9bfbecd86 rdf:first sg:person.01276714415.24
162 rdf:rest Ne4be8c9901124e10b836e079be26258c
163 Nd2e6a089f69c4a11bea25a02ac99b316 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Popliteal Artery
165 rdf:type schema:DefinedTerm
166 Ne4be8c9901124e10b836e079be26258c rdf:first sg:person.01104331243.48
167 rdf:rest N30e82e59b38a4cffa269d7ad96025182
168 Ne9e1cc8ef3694449a3a1014c116e12c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Endovascular Procedures
170 rdf:type schema:DefinedTerm
171 Necbcbf21ace044aea72ded0a906f9224 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Aspirin
173 rdf:type schema:DefinedTerm
174 Nf53b59bcc5d74eb3b29c41e25abc2d75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Middle Aged
176 rdf:type schema:DefinedTerm
177 Nf6ec99423c854f71b7d7883e6d2ad7e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Adult
179 rdf:type schema:DefinedTerm
180 Nf9a028d4b90641ef8de334e2ab07d795 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Vascular Patency
182 rdf:type schema:DefinedTerm
183 Nfc9a7c84cb0f4f51ba5ef349bf1300e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Treatment Outcome
185 rdf:type schema:DefinedTerm
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
190 schema:name Cardiorespiratory Medicine and Haematology
191 rdf:type schema:DefinedTerm
192 sg:journal.1042779 schema:issn 1868-4297
193 1868-4300
194 schema:name Cardiovascular Intervention and Therapeutics
195 schema:publisher Springer Nature
196 rdf:type schema:Periodical
197 sg:person.01016335235.39 schema:affiliation grid-institutes:grid.414976.9
198 schema:familyName Iida
199 schema:givenName Osamu
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016335235.39
201 rdf:type schema:Person
202 sg:person.01052603744.16 schema:affiliation grid-institutes:grid.415432.5
203 schema:familyName Yokoi
204 schema:givenName Hiroyoshi
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052603744.16
206 rdf:type schema:Person
207 sg:person.01104331243.48 schema:affiliation grid-institutes:grid.415432.5
208 schema:familyName Tomoi
209 schema:givenName Yusuke
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104331243.48
211 rdf:type schema:Person
212 sg:person.01222237135.86 schema:affiliation grid-institutes:grid.414976.9
213 schema:familyName Sato
214 schema:givenName Kei
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222237135.86
216 rdf:type schema:Person
217 sg:person.01276714415.24 schema:affiliation grid-institutes:grid.415432.5
218 schema:familyName Soga
219 schema:givenName Yoshimitsu
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276714415.24
221 rdf:type schema:Person
222 grid-institutes:grid.414976.9 schema:alternateName Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan
223 schema:name Cardiovascular Center, Kansai Rosai Hospital, Amagasaki, Japan
224 rdf:type schema:Organization
225 grid-institutes:grid.415432.5 schema:alternateName Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan
226 schema:name Department of Cardiology, Kokura Memorial Hospital, 1-1 Asano, Kokurakita-ku, 802-0001, Kitakyushu, Japan
227 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...